INFINIUM Q4 FY26 results at a glance
INFINIUM PHARMACHEM LTD Q4 FY26 key results metrics| Quarter | Q4 FY26 |
|---|
| Quarter ended | 31 Mar 2026 |
|---|
| Revenue | ₹105 cr |
|---|
| Revenue YoY | +43.8% |
|---|
| Operating profit | ₹8.61 cr |
|---|
| Operating margin | 8.2% |
|---|
| Net profit | ₹6.55 cr |
|---|
| Net profit YoY | +75.1% |
|---|
| Net profit QoQ | +75.1% |
|---|
| Net margin | 6.3% |
|---|
| Basic EPS | ₹4.20 |
|---|
| TTM revenue | — |
|---|
| TTM net profit | — |
|---|
| TTM net margin | — |
|---|
INFINIUM Q4 FY26 results: what the numbers say
INFINIUM PHARMACHEM LTD (INFINIUM) has reported its Q4 FY26 results for the quarter ended 2026-03-31. The company posted revenue of ₹105 cr and a net profit of ₹6.55 cr, translating into earnings per share of ₹4.20.
Compared with the same quarter a year earlier, revenue grew strongly by +43.8% and net profit grew sharply by +75.1%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹8.61 cr, an operating margin of 8.2% versus 8.5% a year ago — a contraction of 0.2 percentage points.
INFINIUM quarter-wise results table
Net profit
₹6.55 cr
+75.1% YoY
Operating profit
₹8.61 cr
+39.8% YoY
INFINIUM PHARMACHEM LTD (INFINIUM) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q4 FY262026-03-31 | ₹105 cr | ₹8.61 cr | ₹6.55 cr | 8.2% | 6.3% | ₹4.20 | +75.1% | +75.1% |
| Q4 FY252025-03-31 | ₹72.73 cr | ₹6.16 cr | ₹3.74 cr | 8.5% | 5.1% | ₹2.57 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
INFINIUM quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
INFINIUM PHARMACHEM LTD quarterly income statement| Particulars | Q4 FY262026-03-31 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹105 cr | ₹72.73 cr |
|---|
| Total expenses | ₹95.97 cr | ₹66.57 cr |
|---|
| Gross profit | ₹19.57 cr | ₹20.12 cr |
|---|
| Operating profit (EBIT) | ₹8.61 cr | ₹6.16 cr |
|---|
| Operating margin | 8.2% | 8.5% |
|---|
| Interest cost | ₹1.24 cr | ₹2.1 cr |
|---|
| Profit before tax | ₹9.51 cr | ₹5.1 cr |
|---|
| Tax expense | ₹1.83 cr | ₹2.09 cr |
|---|
| Effective tax rate | 19.3% | 40.9% |
|---|
| Net profit (PAT) | ₹6.55 cr | ₹3.74 cr |
|---|
| Net profit margin | 6.3% | 5.1% |
|---|
| Basic EPS | ₹4.20 | ₹2.57 |
|---|
| Diluted EPS | ₹4.20 | ₹2.57 |
|---|
INFINIUM results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q4 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +43.8% | — |
|---|
| Revenue QoQ | +43.8% | — |
|---|
| Operating profit YoY | +39.8% | — |
|---|
| Operating profit QoQ | +39.8% | — |
|---|
| Net profit YoY | +75.1% | — |
|---|
| Net profit QoQ | +75.1% | — |
|---|
| EPS YoY | +63.4% | — |
|---|
| EPS QoQ | +63.4% | — |
|---|
INFINIUM annual results history
Full-year performance for INFINIUM PHARMACHEM LTD, useful for reading each quarter in context.
INFINIUM PHARMACHEM LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹190 cr | ₹156 cr | ₹136 cr | ₹114 cr |
|---|
| Total expenses | ₹171 cr | ₹143 cr | ₹120 cr | ₹99.27 cr |
|---|
| Gross profit | ₹41.09 cr | ₹38.11 cr | ₹32.55 cr | ₹33.65 cr |
|---|
| Operating profit (EBIT) | ₹18.51 cr | ₹13.13 cr | ₹15.97 cr | ₹14.96 cr |
|---|
| Operating margin | 9.8% | 8.4% | 11.8% | 13.1% |
|---|
| Interest cost | ₹2.8 cr | ₹3.67 cr | ₹1.89 cr | ₹2.79 cr |
|---|
| Profit before tax | ₹17.84 cr | ₹11.57 cr | ₹15.21 cr | ₹12.95 cr |
|---|
| Tax expense | ₹3.64 cr | ₹3.73 cr | ₹3.71 cr | ₹3.14 cr |
|---|
| Effective tax rate | 20.4% | 32.2% | 24.4% | 24.2% |
|---|
| Net profit (PAT) | ₹12.15 cr | ₹8.15 cr | ₹11.3 cr | ₹9.49 cr |
|---|
| Net profit margin | 6.4% | 5.2% | 8.3% | 8.3% |
|---|
| Basic EPS | — | ₹5.60 | ₹10.61 | ₹6.82 |
|---|
| Diluted EPS | — | ₹5.60 | ₹10.61 | ₹6.82 |
|---|
Revenue trend and demand read-through
Topline for Q4 FY26 came in at ₹105 cr against ₹72.73 cr in Q4 FY25, and ₹72.73 cr in the preceding Q4 FY25 quarter.
On a sequential basis revenue grew +43.8%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹95.97 cr, or 91.8% of revenue, with operating profit grew +39.8% year on year.
Margins, tax and profitability
Net profit of ₹6.55 cr works out to a net margin of 6.3% compared with 5.1% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, INFINIUM PHARMACHEM LTD reported profit before tax of ₹9.51 cr, a tax charge of ₹1.83 cr (effective rate 19.3%), interest cost of ₹1.24 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹3.74 cr in Q4 FY25 to ₹6.55 cr in Q4 FY26, a change of +75.1%.
Trailing twelve months and annual context
On a full-year basis, FY26 revenue was ₹190 cr with net profit of ₹12.15 cr and EPS of —, versus the prior year where revenue grew +21.8% and profit grew +49.2%.
What to watch in the next INFINIUM quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
INFINIUM PHARMACHEM LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
INFINIUM results coverage
No results report published for INFINIUM yet — our desk covers each quarter within minutes of the filing.
INFINIUM quarterly results FAQs
What were INFINIUM PHARMACHEM LTD (INFINIUM) Q4 FY26 results?
In Q4 FY26 (quarter ended 31 Mar 2026), INFINIUM PHARMACHEM LTD reported revenue of ₹105 cr and net profit of ₹6.55 cr, a change of +75.1% year on year on +43.8% revenue growth. EPS stood at ₹4.20.
What is INFINIUM profit margin in Q4 FY26?
INFINIUM PHARMACHEM LTD posted a net profit margin of 6.3% and an operating margin of 8.2% in Q4 FY26. On a trailing twelve-month basis, revenue is — and net profit —.
Did INFINIUM results beat the previous quarter?
INFINIUM PHARMACHEM LTD net profit changed +75.1% quarter on quarter, from ₹3.74 cr in Q4 FY25 to ₹6.55 cr in Q4 FY26.
When are INFINIUM PHARMACHEM LTD (INFINIUM) quarterly results?
INFINIUM PHARMACHEM LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see INFINIUM latest quarterly results?
Results coverage for INFINIUM will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the INFINIUM stock page.
What is INFINIUM PHARMACHEM LTD annual revenue and profit?
For FY26, INFINIUM PHARMACHEM LTD reported full-year revenue of ₹190 cr and net profit of ₹12.15 cr, with EPS of —.
How many quarterly results has INFINIUM declared recently?
Past results dates for INFINIUM will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
